Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + Letrozole in Advanced Breast Cancer
NCT00305825Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2004
- Primary completion
- May 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in breast cancer, sponsored by University of California, San Francisco. Primary endpoints: Safety and Feasibility. Started Aug 2004; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00305825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305825.